614 related articles for article (PubMed ID: 31628177)
1. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
[TBL] [Abstract][Full Text] [Related]
2. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
[TBL] [Abstract][Full Text] [Related]
3. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model.
Piilgaard L; Rose L; Justinussen JL; Hviid CG; Lemcke R; Wellendorph P; Kornum BR
Sleep; 2023 Sep; 46(9):. PubMed ID: 37210587
[TBL] [Abstract][Full Text] [Related]
5. Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need.
Vassalli A; Franken P
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5464-E5473. PubMed ID: 28630298
[No Abstract] [Full Text] [Related]
6. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
[TBL] [Abstract][Full Text] [Related]
7. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
[TBL] [Abstract][Full Text] [Related]
8. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy.
Burlet S; Tyler CJ; Leonard CS
J Neurosci; 2002 Apr; 22(7):2862-72. PubMed ID: 11923451
[TBL] [Abstract][Full Text] [Related]
11. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
[TBL] [Abstract][Full Text] [Related]
12. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
[TBL] [Abstract][Full Text] [Related]
14. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish.
Elbaz I; Yelin-Bekerman L; Nicenboim J; Vatine G; Appelbaum L
J Neurosci; 2012 Sep; 32(37):12961-72. PubMed ID: 22973020
[TBL] [Abstract][Full Text] [Related]
15. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
[TBL] [Abstract][Full Text] [Related]
17. Sleep, sleep disorders and hypocretin (orexin).
Mignot E
Sleep Med; 2004 Jun; 5 Suppl 1():S2-8. PubMed ID: 15301991
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
[TBL] [Abstract][Full Text] [Related]
19. Molecular codes and in vitro generation of hypocretin and melanin concentrating hormone neurons.
Seifinejad A; Li S; Mikhail C; Vassalli A; Pradervand S; Arribat Y; Pezeshgi Modarres H; Allen B; John RM; Amati F; Tafti M
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):17061-17070. PubMed ID: 31375626
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy.
Seifinejad A; Ramosaj M; Shan L; Li S; Possovre ML; Pfister C; Fronczek R; Garrett-Sinha LA; Frieser D; Honda M; Arribat Y; Grepper D; Amati F; Picot M; Agnoletto A; Iseli C; Chartrel N; Liblau R; Lammers GJ; Vassalli A; Tafti M
Proc Natl Acad Sci U S A; 2023 May; 120(19):e2220911120. PubMed ID: 37126681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
